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Foundations and benefactors
Over its 150 year history, many benefactors have supported medical research in the Faculty, both 
as individuals and by contributions to the named foundations. In some instances their names are 
linked to specific grants and awards, providing opportunities for new lines of investigation and for 
the training of young medical scientists to work in specific areas of medical research. No history of 
the Faculty can be complete without credit being given to those who have raised or donated vital 
resources to help the Faculty grow. With its foundations, the Faculty now benefits from a capital 
fund of more than $150 million in endowments, bequests and scholarship funds, too numerous 
to list individually. They vary from the profoundly impactful, such as the Bosch Bequest that 
allowed the formation of the first four research chairs in the Faculty (see Chapter 4), to some with 
terms so tightly worded that the Faculty has had great difficulty in adhering to the donor’s wishes. 
Important foundations, bequests and major fund raising efforts are listed to show the development 
of this aspect of support for the Faculty’s efforts.
The Faculty is very fortunate that the funding available as interest from bequests and donations 
now amounts to around $3 million. It has been a key factor in strengthening research in the Faculty 
overall and in attracting larger scale funding from government. For almost 50 years, the Medical 
Foundation has facilitated major new initiatives both on campus and in the clinical schools. Its 
story and that of some of the 12 other foundations which are focused on individual diseases or 
patient groups are told in this chapter.
For almost 50 years, the Medical Foundation has supported the development of research in the 
Faculty and has facilitated major new initiatives on campus and in the clinical schools. Its story 
and that of some of the other 122 foundations which are focused on individual diseases or patient 
groups are told in this chapter. 
The Medical Foundation
The Medical Foundation was formally established in 1958 as the Post-Graduate Medical 
Foundation of the University of Sydney. It was the brain-child of the University’s own Faculty of 
Medicine, with Victor Coppleson, a man of considerable influence and contacts within medical 
and business circles, the driving force behind its establishment. Coppleson envisaged the 
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possibility that Sydney could become a major force 
in medical research and resolved to use his wide 
contacts in the business world to raise support for 
this development.
From the outset key companies and individuals 
from the corporate sector were attracted to the cause. 
Bill Farnsworth of George Patterson Pty Ltd chaired 
the Foundation’s initial meeting, at which Frank 
Packer of Australian Consolidated Press was elected 
the Foundation’s first President. Another member 
of the initial Council was Robert Crichton-Brown 
of Edward Lumley and Sons (NSW) Pty Ltd, who 
went on to serve as the Foundation’s President from 
1975–1987. 
Following the death of Victor Coppleson in 1965 a special Memorial Fund raised support for the 
construction of the ‘Victor Coppleson Memorial Institute’. It was opened in 1971 in temporary 
premises and moved to a long term home in Western Avenue in 1977.
For many years the Women’s (Auxiliary) Committee members used their contacts in the social 
world to raise funds and awareness of the Foundation. Activities that began with humble 
Christmas card sales, evolved into fashionable events such as a Gala Concert and the Sheepshow 
Ball. There was much support from country members, at least partly in appreciation of the 
Postgraduate Committee’s educational activities in country regions over the years.
By the early 1980s the Foundation was able to broaden its financial contribution beyond only 
‘postgraduate’ support, and in August 1983 its name was changed to The Medical Foundation, 
the University of Sydney. Rather than simply funding short term Postdoctoral, Travelling and 
Medical Research Fellowships, it was able to focus on long term programs. In 1985 this included 
the funding of the University’s Douglas Burrows Chair of Paediatrics and Child Health at a cost 
of $1million over five years. By 1995 it was able to ensure its long term funding. Added to this was 
The Medical Foundation Building seen from 
St John’s Road, Glebe
View of the Camperdown Campus from the Medical Foundation Building
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the Robert W Storr Chair of Hepatic Medicine at Westmead Hospital and the William Chapman 
Fellowship in Cardiology at Royal Prince Alfred Hospital. In 1995 the first of its five-year senior 
project grants valued at $100,000 to $150,000 per annum per fellowship, was granted. This change 
brought more senior researchers to the Faculty who in turn attracted extra funding from bodies 
such as the NHMRC. The Foundation was now hailed as not only as ‘one of Sydney’s oldest 
Foundations’ but also the ‘largest’ with accumulated funds of $21.4 million.
In 2001 the Foundation faced the 21st century with an impressive past financial record and 
confidence in its future role. That year its budgeted medical research expenditure had reached over 
$2.5 million and included allocations to seven current Program Grants and four Special Grants, 
12 postgraduate scholarships, as well financing the Douglas Burrows Chair, and the Robert W 
Storr Chair. 
In 2000 the Foundation’s President, Peter Burrows, began discussions over the development of a 
post genomic biomedical research building. The following year the Foundation agreed to invest 
$10m in the purchase of the old Worksafe building opposite St John’s College on Parramatta 
Road. The building was opened by the Premier, the Hon Bob Carr on 30 November 2004. The 
Foundation had provided the Faculty with a major modern facility. It had also acquired a physically 
identifiable public research presence in the form of the building bearing the Foundation’s name.
In 2004 Peter Burrows indicated that he would not stand for re-election. He was followed by John 
Gregory-Roberts and in 2006 by Richard Caldwell. The Foundation’s assets now total $41million. 
Its strategic support, with the Faculty, of new research endeavours, including its decision to raise 
funds for a Chair of Adolescent Medicine, is assisting the Faculty to further strengthen its leading 
edge research for the benefit of the Australian community.
Abridged with thanks from the History of the Medical Foundation by Tessa Milne.
The Melanoma Foundation
The Melanoma Foundation was established as a foundation of the University of Sydney in 1984. 
Its objective was to foster prevention, treatment and research into melanoma and related skin 
conditions. Over the years the Foundation has evolved into the active and effective body that it is 
today, supporting melanoma research and education in a way that would not otherwise be possible, 
working closely with the co-located Sydney Melanoma Unit, the world’s largest treatment centre 
for melanoma. This partnership has been vital for the Melanoma Foundation to reach one of its 
current objectives to “promote, foster, develop and assist within the University of Sydney and 
elsewhere the study of the causes, prevention and management of malignant melanoma and cancer 
of the skin”.
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One of its most valuable achievements is the support of the Sydney Melanoma Unit clinical 
database, the largest and most comprehensive database of melanoma in the world. This 
database continues to be used as the basis for clinical studies within the SMU as well as for the 
continual review of best practice for the diagnosis and treatment of melanoma through evidence 
based medicine. 
Since its inception the Foundation has raised over $26 million. Following a restructure in 2000 
the Foundation has generated almost $16 million in income with approximately 28% from clinical 
trials, 31% from grants and 40% from fundraising and bequests. Donations and bequests are 
predominantly from the many supporters, relatives and friends who have been touched by this 
most Australian cancer.
Hoc Mai (the Australian Vietnam Medical Foundation)
‘Hoc Mai’ is a Vietnamese phrase that translates into 
English as ‘forever learning’. It has been chosen as the 
name for the Australia Vietnam Medical Foundation.
Hoc Mai was established in 2001 as a Foundation of 
the University at the instigation of Bruce Robinson 
to foster medical education between Australia 
and Vietnam. The Foundation was launched at 
Government House, Sydney in August 2001 and 
brings together the collective medical knowledge of the 
two countries. 
The Foundation expands on the voluntary work 
done in Hanoi by the Northern Clinical School based 
at Royal North Shore Hospital. The initiative is a 
two-way exchange of teaching and learning between 
Australian and Vietnamese health care workers. Hoc 
Mai has plans to expand its program to include mental 
and public health, and research development. 
Hoc Mai has the support of senior doctors and medical professionals in both countries. Her 
Excellency Marie Bashir AC, Governor of New South Wales, is the Patron. The management of 
the business affairs of the Foundation is vested in a Board of Governors.
Hoc Mai
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Amongst its achievements: 
• Medgnosis, a web-based e-Health application has been developed by Dov Hersh of MedTech 
Outreach Australia (an Australian NGO) for Hoc Mai. It connects specialists and academics in 
Sydney with specialists from three hospitals in Vietnam, enabling them to consult each other on 
complicated cases.
• The opening of Hoc Mai House to provide accommodation for up to 300 people a night; 
the relatives and friends of patients as well as some patients awaiting surgery. These people 
previously slept in the grounds of Viet Duc, Hanoi’s largest surgical hospital.
• Scholarships to bring young Vietnamese doctors and allied health professionals to Sydney to train 
for three-month periods. Each scholarship costs $10,000 (incluing airfares, accommodation, 
medical registration, basic expenses) and enables the recipient to work in a major teaching 
hospital of the University of Sydney.
• Scholarships to allow University of Sydney medical students to go to Vietnam during their 
summer break and spend time at hospitals in Hue, Danang, Hanoi or Ho Chi Minh City. The 
students are able to experience at first hand, aspects of health care in a developing country.
The Nerve Research Foundation
The Nerve Research Foundation was established in 1985 to raise funds for research into diseases 
of the nervous system so that better management and treatment could be developed, and to raise 
public and medical awareness of these conditions. The Foundation has fostered research efforts 
into important neurological diseases including Alzheimer’s disease, multiple sclerosis, epilepsy, 
stroke, motor neuron disease, peripheral neuropathy and several hereditary disorders. 
In 1995 the Nerve Research Foundation united with the Institute of Clinical Neurosciences at the 
University of Sydney and Royal Prince Alfred Hospital. The Foundation enjoys a broad base of 
neuroscience expertise – both clinical and basic – and its research efforts include all branches of 
neurological disease.
The Ageing and Alzheimer’s Research Foundation
The Ageing and Alzheimer’s Research Foundation of the University of Sydney (AARF) raises 
funds to support research at the Centre for Education and Research on Ageing (CERA). It is a 
multidisciplinary research centre that aims to expand and share knowledge of human ageing, so 
that the health and quality of life of older people can be improved. It is a joint initiative of the 
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University of Sydney and Concord Hospital. Research at CERA 
aims to study why ageing increases the susceptibility to diseases such 
as Alzheimer’s disease and to develop new therapies for preventing 
and treating illness in older people. 
Since its establishment in 1994 AARF has raised nearly $2 million 
to address its research objectives. Of note is AARF’s support of 
the Sydney Older Persons Study (SOPS) – a longitudinal study of 
community-based elderly looking at the risk factors for disability – 
and its funding of the creation of David Le Couteur’s Biogerontology 
laboratory at the ANZAC Research Institute. In addition, AARF 
supplements grants obtained from competitive funding bodies, 
assists in supporting early career researchers, funds pilot projects 
and ensures the continuing employment of valuable staff.
The Foundation’s objectives are:
• to support research into the phenomena of ageing and Alzheimer’s disease from the medical, 
biological, psychological, sociological and epidemiological points of view;
• to support and encourage cooperation between organisations and individuals interested in 
education and research in the phenomena of ageing and Alzheimer’s disease;
• to support, improve and encourage the education of persons seeking to research the phenomena 
of ageing and Alzheimer’s disease and endeavour to provide career support for them.
The Brain and Mind Institute Research Foundation
Diseases of the brain and mind will soon be the main cause of disability in the world. The Brain 
and Mind Research Institute was founded at the University of Sydney to contribute to the 
elimination of these diseases, capitalising on the completion of the human genome project and the 
ever-increasing sophistication of non-invasive brain imaging techniques. The formation of the 
Foundation to support the Institute in 2003 was guided by Oliver Richter, who introduced David 
Gonski as Chair together with such luminaries as Robert Johnson, a previous Chair of the Reserve 
Band and the pastoralist Tom Cropper as well as Fred Street. These wonderful men all determined 
to raise substantial amounts of the order of millions of dollars for the establishment of the second 
stage of the Institute’s buildings at Mallet St behind the Royal Prince Alfred Hospital. Six million 
dollars had already been raised for stage one of the Institute, that was opened by the Governor of 
NSW Marie Bashir in 2004. 
Ageing and Alzheimer's Disease AARF
For most people, growing old brings great joy and 
fulfillment. Unfortunately old age is also 
associated with increased risk of disability and 
illness. Alzheimer's disease, with its relentless loss 
of memory, is a particular concern for many older 
people.
Our medical research at the Centre for Education 
and Research on Ageing is studying the reasons 
why ageing increases the susceptibility to diseases 
such as Alzheimer's disease, and is developing 
new therapies for preventing and treating illness 
in older people.
The Ageing and Alzheimer's Research Foundation 
(AARF) is a foundation of the University of Sydney. 
Money raised is used to support research at the 
Centre for Education and Research on Ageing 
(CERA) - a joint venture of the University of Sydney 
and Concord Hospital. Money is used to fund 
young researchers, carry out pilot projects and 
continue the employment of valuable staff 
between major funded projects.
AARF supports research with older people in the 
community and in hospital settings
AARF funds are used to support a number 
of laboratory  and community
based research projects
We also study health issues relevant to older 
people in residential and community care and in 
the broader population. 
request your
generous support
Ageing & 
Research Foundation
Alzheimer’s
a
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In 2004–05 members of the Foundation 
made substantial personal contributions 
to the Foundation amounting to $1.75 
million. In late 2004 Ken Parker, the 
present Chair of the Foundation, and 
David Gonski, who retired as Chair 
on appointment as Chancellor of the 
University of NSW, met with the Prime 
Minister to promote the Institute’s 
capital works program for stage two; 
in addition Ken Parker introduced the 
Minister for Education and Science 
Brendan Nelson, to the Institute’s 
activities. As a result of these initiatives 
the Foundation received $5 million from 
the Department of Health and Ageing in 
early 2005 as well as $2 million from the 
Department of Education and Science.
Further substantial amounts from both 
members of the Foundation and the Federal Government are in the process of being raised in 2006 
through the great efforts of Ryan Stokes, Chair of the Foundation in early 2005; Ken Parker the 
present Chair; Tom Cropper; and Robert Johnson. 
In two years the Foundation has raised over $8.75 million. The Institute, University and the wider 
community are in great debt to the Foundation for these magnificent efforts. It is now up to the 
researchers of the Institute to make major contributions to the amelioration of brain and mind 
diseases, so proving that the confidence of the Foundation in its Institute is well placed.
Other foundations supporting the research work of the Faculty include:
• Bone and Joint Research Foundation
• Dermatology Research Foundation
• EAR (Ear and Allied Research) Foundation
• Endocrinology and Diabetes Research Foundation
• Moran Foundation for Older Australians
• Save Sight Institute
Brain and Mind Research Institute Building
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Named chairs
Burrows Chair of Paediatrics and Child Health 
The Medical Foundation’s Douglas Burrows Chair of Paediatrics and Child Health supports 
research into diseases that cause ill health and death in infants and young children. The Chair was 
established in 1983 in honour of Douglas Burrows, Chair of the Children’s Hospital at Westmead 
Board of Management and significant supporter until his sudden death in 1982. To date there 
have been three professors to hold the title of Douglas Burrows Professor of Paediatrics and Child 
Health: Kim Oates (1985–1997); Craig Mellis (1998–2003); Kathryn North (2004–present).
R W Storr Chair of Hepatic Medicine 
Late in 1991 Robert Storr contacted the Faculty and the Medical Foundation to advise of his desire 
to make funds available to the University to support public education about, and research into, 
cancer; particularly liver cancer from which he suffered. Storr died of liver cancer in 1992 soon 
after making arrangements to endow a Chair of Hepatic Medicine at Westmead Hospital. Geoff 
Farrell was appointed in 1993 and continued in the appointment until January 2006, conducting 
interactive programs of clinical and laboratory-based research for the prevention and treatment of 
liver disease. 
Bosch Chairs 
George Henry Bosch, a Sydney businessman, has 
been the Faculty’s greatest benefactor. He was 
born in Victoria in 1861 but moved to Sydney in 
1881 to open a branch of the family watch parts 
and watchmaker’s tools business. The business 
prospered and Bosch became a wealthy man 
retiring in 1924. From 1909 he began to dispose 
of his wealth by supporting various charities, 
in particular medical research in the Faculty 
of Medicine.
Through his generosity, full-time Chairs in 
Histology and Embryology, Medicine, Surgery, 
and Bacteriology were established between 1927 
and 1930. His initial donation was made in 1927 – 
£25,000 for the endowment of a Chair of Histology 
and Embryology. This was followed by a donation 
of £200,000 to provide income for the creation of 
Chairs in the other three disciplines. 
George Henry Bosch
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The Bosch Building and nearby lecture theatres, erected on a site adjoining the Blackburn Building 
in 1965, were named in his honour.
Challis Chair of Anatomy 
In 1890 the University received the Challis Bequest worth over £200,000 and established the 
Challis Chair of Anatomy with the funds. Challis had been a successful businessman in Sydney 
and pastoralist in southern New South Wales. He left the money to his wife with the stipulation 
that following her death, it should pass to the University. Today, Challis’s name is associated with 
Chairs of Anatomy, Biology, Civil Engineering, English Literature, History, Law, Jurisprudence, 
International Law and Philosophy. 
Florence and Cope Chair of Rheumatology 
In 1981 Dorothy Grace Florence endowed the Foundation Chair of Rheumatology at the 
University of Sydney with a gift of $800,000 to the Australian Arthritis and Rheumatism 
Foundation (subsequently Arthritis Australia). Florence became interested in supporting 
rheumatology because of her friendship with John Dick-Smith and his wife Maretta. The 
endowment became known as the Florence and Cope Chair (Cope being in honour of Mrs 
Florence’s uncle, who had left her a legacy which formed the basis of her own investment 
portfolio). In 1983 Peter Brooks was appointed as the Foundation Professor, a position which he 
held until 1991. The Chair is currently held by Philip Sambrook. 
Kellion Chair of Endocrinology 
The Endocrinology and Diabetes Research Foundation was established in 1987 with a generous 
donation from the late Claude Kellion in memory of his son John, who died from complications 
of diabetes at the age of 38. Kellion’s main wish was that an active research program into diabetes 
and its complications should be maintained in the University of Sydney and at Royal Prince Alfred 
Hospital. Its funds provide research support for the Kellion Professor of Endocrinology, Initially 
John Turtle and more recently Dennis Yue have held the Chair.
Scandrett Chair of Cardiology 
In 1996 the National Heart Foundation of Australia (NSW Division), having received funds from 
the Scandrett family, wrote to the University offering “to subsidise a Department or School of 
Cardiology”. The offer was accepted and the Foundation has made a series of annual grants to the 
University to assist the Faculty of Medicine to fund a Chair of Cardiology, which has been held 
successively since 1968 by Paul Korner, David Kelly and David Celermajer.
Plunkett Chair of Molecular Medicine 
In 1983, Edward Henry Plunkett (MB BS 1960), a general practitioner in Eugowra 40km from 
Parkes in central NSW, wrote to the Registrar of the University enclosing a copy of his will that 
left all of his estate for research into molecular biology at the University. He indicated that his wife 
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had made a similar will and that their joint estate 
totalled at the time just under $1 million. Upon 
his death in 1993, his widow Mavis Plunkett, 
provided the University with a copy of her will 
in similar terms, and commenced a series of 
significant, but at the time anonymous, donations 
for medical research, specifically in the area of 
molecular biology. Following her death in 2001 
the University received the proceeds of her estate, 
which allowed it to advertise a Chair of Molecular 
Biology (Molecular Medicine) to which Juergen 
Reichardt was appointed in 2004.
Parker-Hughes Chair of Diagnostic Radiology 
Arnold Ronald Parker-Hughes of Sydney died in 
July 1995 and left the University an estate of $4 
million, subject to a life interest in favour of his 
wife, for the establishment of the Parker-Hughes 
Chair of Diagnostic Radiology. By 2005 the 
University had received some $6 million to establish a Chair. It is the intention of the Faculty to 
develop an academic unit around the Chair, using and advancing the latest techniques of medical 
imaging in the Brain and Mind Research Institute.
Raymond E Purves Chair of Dermatology 
The Raymond E Purves Chair of Dermatology was established in 1988 and was the first Chair of 
Dermatology in Australia. The bequest supports research into dermatology. The Chair will become 
vacant in May 2006, following the retirement of Ross Barnetson, the current incumbent.
Other bequests
Over very many years in the Faculty of Medicine has been fortunate to receive bequest support for 
research without the specification that the funds be used to establish professorial positions such as 
those above. Recent examples include the following:
• Harry and Hilary Bode Bequest “for the purposes of medical research… at the discretion of the 
Dean of the Faculty”
• Elsie Mary Thompson Bequest for “the promotion of medical research within the Faculty of 
Medicine”
• Evelyn Pigot Bequest for scholarships to support research
Molecular biology
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The development of the concept independent medical research 
institutes concept in New South Wales
As has been outlined in Chapter 4, two of the earliest medical research institutes in New South 
Wales (Kanematsu and Kolling) were established during the 1930s in relation to teaching 
hospitals of the Faculty of Medicine. Until then, medical research in New South Wales was mainly 
conducted by the full-time academic staff in the medical science departments on campus, although 
their funding allocations were very limited because the University concentrated its resources more 
on its teaching role. The two hospital-based, but basic science-oriented, institutes pioneered the 
‘bench to bedside’ concept of medical research.
Kolling Institute for Medical Research
Following World War I, the Royal North Shore Hospital Board adopted the principle that “medical 
research must go hand-in-hand with curative medicine”. This led to the establishment of the 
‘Institute of Pathological (later Medical) Research of New South Wales’ in 1920. W W Ingram, 
anatomical pathologist at the hospital, was appointed Honorary Director and fulfilled this role until 
he retired in 1974. Financial support came from donations and hospital funds. The ‘Kolling’ name 
commemorates Eva Kolling, who made a substantial donation in 1929 in memory of her husband 
Charles, and left a further bequest on her death in 1941. Biochemical research commenced in 
1925 with the appointment of T E Rofe who was succeeded by Rudi Lemberg who was Assistant 
Director from 1935 until 1972 and maintained his stellar international career working on the 
biochemistry of haem pigments after fleeing Nazi Europe.
The research direction turned to immunology and cell biology when David Nelson became the 
first full-time director in 1974. Staff numbers grew to about two dozen as support was increasingly 
derived from competitive research schemes but involvement in hospital service became more 
remote. After the untimely death of Nelson in 1981 there was an interval until the appointment in 
1994 of Rob Baxter who has overseen great expansion and diversification of research. 
There are now almost 120 staff and students, divided into eight research groups: Growth, 
especially insulin-like growth factor; Cancer Genetics, particularly of endocrine tumours; 
Perinatal; Renal; Pain Management, Neurogenetics including the genetic basis of hearing loss, 
Laboratory and Community Genetics; and Cardiac. They are located in the 85-year-old Kolling 
Institute building and various laboratories scattered around the RNSH campus. Relocation into 
the RNSH research facility, currently in planning stage, is eagerly awaited.   
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Kanematsu Laboratories
In 1933 the Kanematsu Institute was 
built as an institute of pathology at 
Sydney Hospital as a memorial to 
Fusajiro Kanematsu and his wife. The 
funds were donated by the Japan-
Australia trading company he had 
founded in 1889. When he died in 
1913, Kanematsu bequeathed the firm 
to his employees. Kanematsu-Gosho 
is still very active in trade between the 
two countries. The first Director Keith 
Inglis, remained an active supporter 
of research at the Institute after he was appointed as the first Professor of Pathology in Sydney 
in 1937, although there were ongoing ‘town and gown’ rivalries. John Eccles, the next director, 
was joined by Bernard Katz and both were awarded the 1963 Nobel Prize for their work on the 
electrophysiology of synaptic transmission. F C Courtice (director 1947–58) and Malcolm Whyte 
(1960–66) were almost as eminent. Both these directors left the Institute for greater research 
opportunities at the new Australian National University where Eccles also worked after a period 
in Otago. 
The Kanematsu was the home of the Red Cross Blood Bank during World War II and haematology 
became the main thrust of research on the appointment of Fred Gunz as Director (1968) with the 
separation of the routine diagnostic services and the research laboratories. Paul Vincent, appointed 
director in 1980, maintained the focus on haematological malignancies but had the 14 melancholy 
task of negotiating the transfer of a much diminished staff to the Central Sydney/Blackburn 
Campus when Sydney Hospital ceased to be a general hospital in 1982. The identity of the 
Kanematsu has been its focus on molecular aspects of leukaemia and related malignancies. 
Children’s Medical Research Institute
The present free-standing institute on the 
Westmead campus, which is home to almost 
120 staff, evolved from small beginnings. On 
his retirement in 1958, Lorimer Dods started 
a foundation to raise funds for research at 
the Royal Alexandra Hospital for Children 
in Camperdown and in the neonatal units 
associated with the obstetric hospitals. 
Fusajiro Kanematsu and his wife
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This Children’s Medical Research Foundation 
supported specific clinical research projects in 
rubella, anaemia and care of premature babies. 
The groups were soon brought together under 
the direction of John Harley, but the work and 
administration were disrupted by closure of Crown 
Street Hospital and repeal of the Royal Alexandra 
Hospital’s Act of Parliament in 1984. 
The Foundation was then reconstituted as 
an independent entity under the direction of 
Peter Rowe who had been appointed as the 
Lorimer Dods Professor in 1980. He encouraged 
fundamental scientific work on the molecular basis 
of growth and development and the application 
of the basic concepts and techniques arising 
from this research to diagnosis, management 
and prevention of childhood diseases. A research 
building was constructed in the Camperdown hospital grounds but was scarcely occupied before 
a second relocation was necessary in 1992 when the entire hospital was moved to its present site 
at Westmead. It now occupies modern research facilities between Westmead Hospital and the 
Children’s Hospital at Westmead with strong links to both their associated clinical schools of the 
Faculty. Rowe will retire in 2006. 
The Institute houses the Australian Cell Bank which is supported by the NHMRC, Cure Cancer 
and the National Breast Foundation funds. It accepts responsibility for research students from 
University of NSW and University of Newcastle, as well as from the University of Sydney. 
A W Morrow Gastroenterology and Liver Centre
The Centre was founded at Royal Prince Alfred Hospital in 1948 to support research in what was 
then an emerging clinical specialty. It was named in honour of its first director William Morrow, 
a leading gastroenterologist who, with Stan Goulston pioneered the introduction of endoscopy in 
Sydney. He was succeeded in turn by Alan Skyring and Neil Gallagher. The present director is 
Geoff McCaughan.
The Centre operates in close contact with gastroenterology clinical services and the liver transplant 
and liver cancer groups in the hospital, as well as having laboratories in the Centenary Institute 
(see below). It is undertaking basic and clinical research into inflammatory bowel disease, viral 
hepatitis, cirrhosis and liver cancer and basic research into the immunobiology of liver disease and 
Lorimer Dods
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liver transplant tolerance. Support for the staff 
of research nurses, clinical fellows and research 
scientists is derived from the Bushell Foundation, 
the NHMRC and other competitive grant schemes. 
Sydney Melanoma Unit
In 1961 Gerald Milton moved from Royal 
Prince Alfred Hospital to set up a sub-unit of the 
Department of Surgery at St Vincent’s Hospital, 
then a teaching hospital of the University of Sydney. 
His interest and experience in melanoma extended 
and, following the advice of John Loewenthal, 
he began to specialise in the treatment of patients 
with melanoma. In 1966 he relocated his clinical 
and research activities to Sydney Hospital and 
then in 1982 back to Prince Alfred as successive 
rearrangements in teaching hospital positions 
followed the establishment of the medical school at the University of New South Wales and Area 
Health Service restructuring. 
Because the incidence of melanoma was gradually increasing, Milton envisaged the need for a 
databank to study the natural history of the disease. In 1969, he commissioned Helen Shaw to 
establish a register of personal and clinical patient data. This has grown to be the largest and most 
comprehensive of its kind in the world with entries for over 22,000 patients. 
Milton was joined first by Bill McCarthy and then by John Thompson. As successive Directors 
they have worked to expand the clinical and research capability of the unit. The unit brings 
together surgeons, medical oncologists, pathologists and radiotherapists to achieve the best 
outcome for individual patients. Its research is mainly epidemiological and the database is 
providing evidence for preventive and early detection programs. The success of the programs 
to arouse public awareness is evident in the ubiquitous floppy school hats, now mandatory in 
most school playgrounds. Following very significant donor support, the unit is about to enter a 
new phase of development with its projected move to the Mater Hospital to expand laboratory 
research capability.
Institute of Anatomical Pathology at RPAH
Under successive Directors Vincent McGovern (1977–1980), Alan B P Ng (1980–1995), Peter 
Russell (1995–2003), Paul McKenzie (2003–current) the staff specialists and clinical academic 
pathologists associated with the Department of Anatomical Pathology at RPAH have participated 
 Bill McCarthy
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in numerous large collaborative research programs. Most are translational research projects in 
breast cancer, prostate cancer, gastroenterological tumours and melanoma. Funding sources 
include the NHMRC and the NSW Cancer Institute. 
Institute of Clinical Pathology and Medical Research (ICPMR)
When Westmead Hospital was opened in 1978, its diagnostic services became the responsibility 
of the ICPMR which was formed from units of the former NSW Health Department Laboratory 
services and was directed by Harry Kramer. These functions continue under its present director 
Cres Eastman, but the research interests have broadened to include population studies of iodine 
deficiency in Australia, aspects of transplant immunology and pollution, and drug and infectious 
disease monitoring in the environment and community. It makes a major contribution to clinical 
research in the Western Clinical School and beyond by providing sophisticated screening tests and 
in-depth investigation of positive samples from study patients. ICPMR incorporates the Western 
Sydney Area Pathology Service and the Division of Analytical Laboratories. ICPMR is probably 
best known as Australia’s most comprehensive provider of pathology services. As well as servicing 
hospitals and laboratories in Western Sydney, it provides tertiary services throughout NSW and, 
where appropriate, throughout Australia and even to some overseas centres. ICPMR staff also have 
a commitment to fostering excellence in clinical care, public health, teaching, training and medical 
research. They have been working on issues as diverse as improving the health of children in Tibet 
to fighting heart disease and cancer, and helping solve crimes. It is a provides comprehensive 
diagnostic pathology services to hospitals and laboratories in Western Sydney. It is involved in 
many large scale research programs such as population surveys for thyroid deficiency. 
Cres Eastman ameliorating thyroid deficiency in Tibet
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Department of Endocrinology at Royal Prince Alfred Hospital and the Kellion 
Diabetes Research Foundation
Funded initially by a donation from Claude H Kellion, as a land package sold for $1.3 million, the 
Foundation-supported research comprises both clinical and laboratory arms. Across the 28 years 
since 1978 it has supported research programs in diabetes, andrology, growth factors, metabolism, 
obesity and thyroidology. Directly from the Foundation support in research, four world class 
researchers evolved and have become professors and leaders in their respective fields (Rob Baxter, 
Ian Caterson, David Handelsman and Dennis Yue). The current research focus is on diabetes and 
its complications and endocrine tumorigenesis, particularly prostate and thyroid cancer. 
The endocrinology research group was established to act as a focus for the active research program 
in diabetes and general endocrinology on-site at the University of Sydney and Royal Prince Alfred 
Hospital. It was led initially by John Turtle (Kellion Professor 1988–2002) who has been followed 
by Dennis Yue. The resources of the Foundation are commonly used to supplement external grants 
by supporting postgraduate training in endocrinology, providing scholarships for higher degrees 
and purchasing key resources and equipment.
The Foundation is currently being linked in with a Centre concept for Diabetes and Endocrinology 
to formalise the University of Sydney and Royal Prince Alfred Hospital links in endocrinology 
basic and clinical research, and to help in establishing ‘bench to bedside’ and translational research. 
Collaborative work is undertaken with other research groups on site, including pharmacology, 
hepatology and cardiology.
The research institutes
In 1984, the NSW Government officially encouraged the development of medical research 
institutes, setting up a research department of St Vincent’s Hospital as the Garvan Institute 
(affilicated with the University of NSW). Another new institute was conceived in 1982 as part of 
the commemoration of the centenaries of the University of Sydney Medical School and the Royal 
Prince Alfred Hospital. It was formed around the strong immunology research group of Tony 
Basten (the Centenary Institute of Cancer Medicine and Cell Biology).
During the last 15 years there has been an explosion in the number of institutes formed. Some such 
as the George Institute, have been attracted to the Faculty by the example of the existing centres. 
Others, like the Westmead Millenium Centre and the ANZAC Research Institute, reflect the 
aspirations and initiatives of their individual Clinical Schools. Many, however, are a response to 
changes in government funding policies. At exactly the same time, the UK government was forcing 
some its London-based independent medical research institutes to merge with adjacent multi-
disciplinary Universities, the NSW government was introducing a funding scheme that forced 
similar institutes to be more independent to receive healthy government infrastructure funding. 
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Woolcock Institute of Medical Research
The Woolcock Institute of Medical Research 
Limited (known then as the Institute of Respiratory 
Medicine Limited) was incorporated in 1981 and 
opened by the then NSW Minister for Health, the 
Hon R J Mulock, on 22 November 1985.
The Institute was established to facilitate the 
research activities of staff of the Departments 
of Respiratory Medicine in the University of 
Sydney and at Royal Prince Alfred Hospital. 
In the initial years of its development, research 
activities within the Institute focused mainly on 
asthma and allergy. More recently the Woolcock 
has seen a considerable increase in the scope 
of its activity and now has active groups with 
critical mass in physiology, imaging, cell biology, 
epidemiology, sleep and upper airways, chronic 
obstructive pulmonary disease, asthma, allergy, 
cystic fibrosis, smoking cessation and a clinical 
trials unit. In addition, the Woolcock has bioengineering capabilities, utilising the latest technology 
in electronics, software and analysis to make devices in support of research. Its inaugural operating 
budget was $73,000, while in 2005 it reached $6 million with over 50 research projects in progress. 
Industry now provides 60% of the funding which comes in many forms, from grants to support 
individual employees or an area of research through to contracted services such as clinical trials 
and consultancies.
It was originally housed in Page Chest Pavilion at Royal Prince Alfred Hospital. In 1997, the 
Reid Charitable Trust refurbished premises in Building 82, Royal Prince Alfred Hospital for the 
Institute. On 31 August 2002, the Institute changed its name to the Woolcock Institute of Medical 
Research in memory of Ann Woolcock, the founding director. Its present director is Norbert 
Berend, supported by the Kinsley bequest at the University of Sydney. 
Growth of the Woolcock and the refurbishment of the Hospital have forced its fragmentation 
across the RPA and University of Sydney campuses in 2004. A dedicated research facility 
will, however, house the Woolcock under one roof. In Glebe Point Road, it will bring together 
world-class researchers and advanced technologies to support a cooperative, innovative research 
environment that fosters the sharing of knowledge.
Ann Woolcock
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The Woolcock Institute of Medical Research 
has active associations with Hunter Area Health 
Service and the University of Newcastle and 
Liverpool, Concord and Royal North Shore 
Hospitals. The Woolcock is a company limited 
by guarantee and is recognised by the NHMRC 
as an independent research institute and is a 
member of the Association of Australian Medical 
Research Institutes. The Woolcock is a major 
partner in the Cooperative Research Centre for 
Asthma, which has been expanded and renewed 
for another seven years as the CRC for Asthma 
and Airways. The Woolcock has also established 
the Australian Centre for Asthma Monitoring for the Australian Institute of Health and Welfare 
and is the administering institution for the Centre for Clinical Research Excellence in Respiratory 
and Sleep Medicine.
In 25 years the Woolcock has seen a considerable increase in the scope of its activity and employs 
over 100 staff. Recent advances form the group include identification of a growth factor receptor 
which is lacking in bronchial muscle cells of asthmatics and quantification of risk factors for 
development of childhood asthma. Education and health promotion are also major activities of 
the Centre while new research initiatives include studies of chronobiology and the effect of sleep 
deprivation on health.
The Centenary Institute Cell Biology and Cancer Medicine
The Centenary is a corporation established in 1985 under an Act of the NSW Parliament in 
response to a perceived need to create centres of research excellence in NSW which could be 
eligible for NHMRC block funding. NSW Health continues to contribute to the operational 
(general and research infrastructure) costs of running Centenary. Historically Centenary can be 
regarded as part of the second wave of independent Australian medical research institutes modelled 
on the highly successful institutes in Victoria. It has generated substantial grant and infrastructure 
funding to the University of Sydney and RPA Hospital campus. 
When it opened in 1989 under the direction of Tony Basten it was based on the Director’s 
Commonwealth Centre of Excellence (the Clinical Immunology Research Centre) comprising 25 
staff. For the first 10 years of its existence the research program was exclusively immunological, 
but has since been expanded to include molecular medicine. The Centenary provides shared core 
resources to all its staff as well as collaborators from the university, hospital and other research 
centres locally and interstate. These include a sophisticated SPF level 2 animal facility, a flow 
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cytometry facility and centralised micro-injection service for transgenic mice which are a key 
resource for studying gene function in vivo. It also provides its lecture theatre and associated 
amenities to university, hospital and external organisations for teaching activities and seminars. 
The Centenary enters a new phase of its history with Basten’s retirement and is presently under 
its interim director David Burke – a renowned neurophysiologist – who is Dean of Research and 
Development of the College of Health Sciences and chairs the Faculty’s research committee. 
Research staff work within a series of programs, currently: B cell biology (Tony Basten); 
Mycobacterial infection (Warwick Britton); T cell biology (Barbara Fazekas); liver immunobiology 
(Geoff McCaughan); gene therapy (John Rasko); molecular cardiology (Chris Semsarian); cellular 
immunology (Jon Sprent).
Several of these groups have strong links with RPAH (McCaughan is Director of the AW 
Morrow Centre for Gastroenterology and Liver Diseases) and the University (Britton is Head 
of the Discipline of Infectious Diseases and Immunology as well as Head of the Department of 
Medicine). The annual budget has doubled since 2000. 
Centenary Institute
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Save Sight Institute
The Institute which operates within the environment of the Sydney Eye Hospital was opened 
in 1985 under the leadership of Frank Billson and with ongoing support from the Lions Club 
organisation for its work in community ophthalmology. The Eye Bank is its responsibility and as 
well as providing an essential service which enables 400 corneal grafts to be performed annually, it 
undertakes research into methods of preserving and culturing corneal cells. 
The institute’s clinical staff also conduct research and have established leadership in 
electrophysiological measurement of visual fields (pioneered by Alex Klistorner) and the early 
detection of glaucoma. They are also actively involved with clinical trials of new diagnostics 
and therapies. 
In 2000 the Sydney Foundation for Medical Research funded a Chair of Experimental 
Ophthalmology. John McAvoy was appointed and now heads laboratory research in the Institute. 
His group studies the growth and development of the eye and especially the lens; he will soon be 
supported by a new appointee.
The location in close association 
with the active clinical work of 
the eye hospital fosters rapid 
translation of research findings 
into clinical practice and allows 
many trainee specialists the 
opportunity to participate 
in research.
Institute of Endocrinology 
and Diabetes
The Institute of Endocrinology 
and Diabetes was established at 
the Royal Alexandra Hospital 
for Children in 1987 under the 
leadership of Martin Silink and 
more recently Chris Cowell. It 
was re-located with the hospital 
to Westmead and now includes 
a large clinical department of 
Frank Billson and patients in Bangladesh
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paediatric endocrinology and diabetes and a strong clinical research program. This is focused on 
diabetes epidemiology – the causes of type 1 diabetes and strategies to prevent it; development of 
diabetes complications, including genetic mechanisms and insulin resistance. The bone research 
group is developing imaging techniques to assess paediatric bone and studying the role of exercise 
in development of bone. The Institute maintains the national database for children receiving 
Growth Hormone, OZGROW, and participates in the national epidemiology database for children 
with diabetes. 
Heart Research Institute (HRI)
Opened in 1989, the HRI building adjacent to RPAH in Missenden Road is an independent 
institute with Roger Dean as the founding director. Philip Barter was recruited from Adelaide to 
act as Director from January 2003, following the move of Dean to become Vice Chancellor of the 
University of Canberra. The HRI now includes 45 scientists, 15 graduate students, four laboratory 
and biological support staff and 10 administrative and fundraising staff. Working in seven research 
groups, their mission is to develop new scientific knowledge that will lead to prevention and early 
detection of atherosclerosis. The Institute was established as a combined initiative of the National 
Heart Foundation and cardiologists at RPAH. It was supported by a Commonwealth government 
bicentenary initiative to further knowledge about the major origin of cardiovascular disease, 
to improve methods of prevention, diagnosis and treatment and to provide related educational 
programs. It boasts excellent facilities for cell and molecular biology and for small and medium 
sized animal research. Funded by research grants, RPAH cardiologists, and fundraising, the 
Institute has many national and international collaborations. Its main basic research achievements 
are in the area of lipoproteins and antioxidants and it is clinically active in development of non-
invasive tests for vascular disease.
Institute of Clinical Neurosciences at Royal Prince Alfred Hospital
The Institute of Clinical Neurosciences was established under the direction of Jim McLeod in 
1991 to provide research and teaching in the field of clinical neurosciences and to investigate and 
treat diseases of the nervous system. It consists of the Departments of Neurology, Neurosurgery 
and Neuropathology at Royal Prince Alfred Hospital, together with the appropriate academic and 
research staff at the University of Sydney. It also includes relevant members of the Departments 
of Nuclear Medicine, Rehabilitation and Psychiatry and relevant allied health professionals and 
nursing staff at Royal Prince Alfred Hospital. The current Director is John Pollard. 
NHMRC Clinical Trials Centre 
The CTC was established in 1988 as a research unit of the National Health and Medical Research 
Council. It runs large multicentre clinical trials, takes part in trials of national and international 
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collaborative trial groups and contributes expertise to trials run by others. It also undertakes 
research into trial methods and reviews evidence from completed trials. For groups wanting 
to run their own trials, the CTC will advise on trial design or operation, randomise patients or 
analyse data.
The CTC offers placements for postgraduate students, trains its own staff and runs short courses 
in the design and conduct of clinical trials as part of its undertaking to train people for Australian 
medical research.
Core funding is provided by the NHMRC and specific trial projects are funded by a variety of 
external bodies, including government, public and private institutions and the pharmaceutical 
industry. The CTC’s mission is to achieve best practice in health care and improve outcomes 
in Australia and internationally through the use of clinical trials research. The Director is John 
Simes a renowned cancer researcher and the deputy director is the cardiovascular trials specialist 
Tony Keech.
Australian Centre for Health Promotion
The centre was established in 1990 within the School of Public Health with Don Nutbeam as 
Director (now acting in the newly-created position of Provost, recently Pro-Vice-Chancellor, 
College of Health Sciences). Four year start-up funding was provided by the Commonwealth 
Public Health Education and Research Program to support the development of innovation in 
health promotion teaching and research. Ongoing funding has come from a NSW Research and 
Development infrastructure grant and research grants, consultancies, and short courses and 
workshops. The current Director is Marilyn Wise, and there is one other paid staff member. Each 
of the Directors contributes significantly to the Centre’s work from their substantive roles rather 
than as ‘employees’ of the Centre. Located within the School of Public Health at the University, 
the Centre contributes to the School’s work – contributing to graduate teaching in public health, 
supervising PhDs, course design, and research development. Research includes: 
• descriptive studies of incidence, prevalence of public health problems and or associated risk and 
contributing factors; 
• evaluation of health promotion interventions;
• investigation of effective methods to promote health – e.g. intersectoral action, social marketing, 
policy development and implementation;
• review and development of national/state health and health promotion policy and programs.
The Centre works in partnership with public and private organisations in the fields of public health 
and health promotion. Current partnerships are with the Australian Indigenous Health Promotion 
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Network, the NSW Centre for Overweight and Obesity, Human Capital Alliance, and the NSW 
Centre for Primary Health Care Research.
Family Medicine Research Centre
The Family Medicine Research Centre, incorporating the Australian General Practice Statistics 
and Classification Centre, was established under the direction of Helena Britt in 1990 at 
Westmead Hospital; it became an independent University centre in 1998. It operates purely on 
external funding, mostly non-competitive research funds, from both government and private 
industry. The Centre is a collaborating centre of the World Organisations of Family Doctors 
(WONCA). The interdisciplinary team concentrates on health services research and development 
in general practice. Its BEACH (Bettering the Evaluation and Care of Health) database now 
includes information regarding more than 700,000 GP-patient encounters. The data are used by 
government, industry and academic researchers to describe and evaluate the care provided. 
Centre for Perinatal Health Services Research
The NSW Pregnancy and Newborn Services Network (PSN) was established in 1991 to assist 
NSW Health in the planning, coordination and evaluation of care for high risk pregnant 
women and high risk newborn infants. In 1996 the Centre was established as its research arm 
with David Henderson-Smart as Director. It conducts research into rates and risk factors for 
perinatal mortality and the impact of perinatal 
conditions on long term developmental disorders 
in children. It also appraises evidence for the 
effectiveness and efficiency of various forms of 
obstetric and neonatal care as part of the Cochrane 
Collaboration. In 1997, Christine Roberts joined 
the group as Director of research. The Centre is 
located in the Queen Elizabeth II Building on 
campus and is a centre of the Faculty’s School of 
Public Health.
Pain Management Research Institute
The PMRI was established by Michael Cousins 
soon after his appointment to the Chair of 
Anaesthesia at the Northern Clinical School 
in 1991. The initial focus was on clinical and 
epidemiological research for which it now has 
an enviable international reputation. It has since 
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developed very strong basic research into pain pathways (led by Janet Keast) and new treatment 
options based on molecular studies (directed by Macdonald Christie who heads the basic 
research program). Behavioural studies and their application to patient management is a major 
focus, while there are human and animal projects on the pharmacodynamics of local and general 
anaesthetic agents. 
The work of each of the groups is funded by research grants and industry partnerships as well as by 
public and community donations. The Institute is now a division of the Kolling Institute.
Centre for Infectious Diseases and Microbiology 
The Centre arose out of the Institute for Clinical Palthology 
and Medical Research in 1992 as a Centre of Excellence 
for the provision of clinical and laboratory services, and to 
offer internationally competitive educational and research 
programs in Infectious Diseases and Microbiology. It now 
comprises CIDM Biomed (directed by Tania Sorrell) and 
CIDM Public Health (headed by Lyn Gilbert). The Centre 
is part of the Westmead Millennium Institute. Basic research 
is being undertaken into mycology and bacterial pathogenesis 
as well as translational work on the use of novel molecular 
technologies and Nuclear Magnetic Resonance in diagnosis of 
infection. The public health group supports epidemiological 
and risk assessment studies of important infections and potential agents of bioterrorism. The 
unit is also home to the NHMRC Clinical Centre of Excellence in Infections and Bioethics in 
Haematological Malignancies.
Centre for Behavioural Sciences in Medicine
The Centre, directed by Susan Hayes, is located in the Blackburn Building. It has provided a focus 
for research in the discipline of Behavioural Sciences since 2000, when the former Department 
of Behavioural Sciences was incorporated into the large Department of Medicine in the Central 
Clinical School. The Hayes Ability Screening Index is widely used in assessment of intellectual 
impairment in young offenders and she is currently supervising four PhD students’ research 
projects on psychological aspects of disability. Support is derived from competitive grant schemes 
and governmental contract research funding. The Centre is active in setting parameters for 
disability and contributing to social policy and legislation concerning the disabled.
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Nepean Hospital Gastroenterology Research Unit
The unit was established in 1994 to create a research environment in a newly established teaching 
hospital, to be directed by Nicholas Talley. A foundation donation by Jannsen Pharmaceuticals 
and ongoing support by the Nepean Research Foundation, as well as research grants for specific 
projects, have resulted in over 150 publications and the training of 14 PhD students. Facilities 
include a laboratory and endoscopy unit. Research interests include diabetes mellitus and obesity 
in relation to gastrointestinal disease.
ANZAC Research Institute
The ANZAC Health and Medical Research Foundation (the legally incorporated company which 
operates the ANZAC Research Institute) was established in 1994 when Concord Hospital was 
transferred from the Commonwealth repatriation system to NSW Health. Strongly supported 
by the then Dean John Young, it was designed to secure the first dedicated research infrastructure 
for Concord Hospital and by 1997 – after obtaining Federal and matching State government 
support ($3m each) – it appointed David Handelsman (then based at RPA) as Director to 
design and establish the Institute, which opened in late 2000 in its architectural prize-winning 
building with two research groups (andrology and neurobiology). Biogerontology, bone biology, 
cancer pharmacology, vascular biology and two start-up biotechnology companies have now 
been added. Almost 80 full-time equivalent scientists work in modern laboratories with state-
of-the-art equipment. The overarching focus is on ageing, and each laboratory is closely linked 
with a research-oriented hospital department to ensure effective ‘bench to bedside’ dialogue. 
Infrastructure support now comes from the NSW Research and Development Infrastructure 
Grants Program, fundraising and commercialisation. All project specific funds are won from peer-
reviewed research grants, and commercial contracts with private and public sector organisations. It 
is still led by the inaugural director, Handelsman.
The ANZAC Research Institute at Concord Hospital
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Centre for Developmental Disabilities
The multidisciplinary Centre, directed by Trevor Parmenter, and located at Royal Rehabilitation 
Centre Sydney (in Ryde) was established in 1995 with support from the NSW Departments 
of Health and Community Services and the Motor Accidents Authority. A major impetus was 
the downscaling of large institutions that cater for the developmentally disabled. The major 
research areas are service delivery and policy issues of health and community living. Teaching has 
concentrated on the need to prepare doctors and allied health professionals to meet the needs of 
those who would increasingly live in the general community.
The Centre has strong links with similar research and development centres in Australia. A health 
clinic supports general practitioners who generally do not have experience with adults with a 
developmental disability.
Research output has been consistently high over the Centre’s 10 years of operation, but its major 
handicap is the lack of infrastructure support that limits the Centre’s opportunity to prepare grant 
applications whilst having to engage in income-producing activities to stay in existence.
NSW Breast Cancer Institute
The Institute is a multidisciplinary unit created in 1995 within Sydney West Area Health Service 
and located at Westmead Hospital. The founding Director is John Boyages and its three programs 
– Clinical, Research, Education – are 75% funded by NSW Health and 25% by public donations. 
Epidemiological research based on the large 
number of patients in the clinical program (almost 
1000 new patients are seen annually) has been 
focused on prognostic factors, breast conservation 
and sentinel node biopsy. Recent grants include 
a joint initiative with the Westmead Institute for 
Cancer Research for Australia’s first breast cancer 
tumour bank. The Institute has also published 
widely on hormone replacement therapy (HRT) 
and breast cancer.
The education program overlaps with research at four-yearly Leura International Breast Cancer 
Conferences in Australia, which in 2004 registered 728 people. The unit also holds an annual 
Breast Cancer Public Forum which is broadcast live with Sky Channel across 55 locations across 
the country and reaches thousands of women. The Institute has also developed a handbook of 
clinical protocols for breast cancer clinicians and is constantly producing new and updated patient 
information brochures.
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Institute for Magnetic Resonance Research
Founded in 1995 by a group of medical specialists and scientists, under the leadership of Carolyn 
Mountford, the Institute for Magnetic Resonance Research (IMRR) benefits Australia through 
researching, developing, applying and commercialising technologies associated with the use of 
magnetic resonance for the detection, diagnosis and treatment of human diseases.  
The Institute has adopted a multidisciplinary approach to the investigation of medical applications 
of magnetic resonance technology and is currently participating in international trials to determine 
the clinical benefit of magnetic resonance for healthcare outcomes, and budgets, and to ensure 
Australia has immediate access to clinical developments in magnetic resonance.  
The Institute team is working on the development of suitable devices and protocols for in vivo 
magnetic resonance to allow the simultaneous identification of spatial location and pathological 
diagnosis of disease states, and has a commitment to provide world class training in applications of 
magnetic resonance technology in the field of medicine.
Centre for Education and Research on Ageing
The Centre was established in 1995 to focus on research into ageing and especially dementia, 
initially under the leadership of Tony Broe. The research interests broadened to include the effects 
of age-related changes in the liver on metabolism of drugs following David Le Couteur’s succession 
as Director in 2000. The Centre is located at Concord Hospital and is supported by competitive 
research grants, direct Health Department funding and the Ageing and Alzheimer’s Research 
Foundation (AARF). Currently it is conducting large studies on the epidemiology of ageing and 
the pathology of degenerative disease of the brain. The educational program targets both the 
community and the health care professions. The Centre is one of the core members of the ANZAC 
Research Institute.
Institute for Immunology and Allergy Research 
The Institute developed out of the basic clinical research efforts in immunology at Westmead 
Hospital in 1995 with Graham Stewart as Director. The backbone of funding has been NHMRC 
and ARC Linkage Project Grants. In addition the Institute has attracted NSW government 
infrastructure funding since the inception of that scheme. In 1996–2000 the Institute held and 
administered an Research and Development Grant from the Australian government ($5.6m). It 
also receives private donations and partnership grants from industry.
The Institute was one of the four founding groups of the Westmead Millennium Institute. In basic 
research, it has a particular focus on mechanisms by which inherited variation in the immune 
response contributes to important human diseases, including autoimmune disease (multiple 
sclerosis, diabetes), infectious disease (HIV, hepatitis C) and allergic disorders (atopic dermatitis, 
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asthma). International collaboration ensures the 
power and replication of these studies. In addition 
to basic research, the Institute has carried out 
studies on aerobiology and the affects of airborne 
allergens on elite athletes under the direction of 
Connie Katelaris. In recognition of its community 
responsibilities, the Institute provides pollen count 
daily for Channel 7 news each year during the peak 
pollen season.
Westmead Millenium Institute
The foundation of the Institute as a grouping of the four largest research units which had 
developed in the Westmead Clinical School was catalysed by the appointment of a Professor 
of Research Medicine in 1996. A NSW Health Infrastructure funding grant supported the 
construction of a new building on the hospital site. It was opened in 2000 and now houses over 300 
research workers. The four foundation groups – virus research led by Tony Cunningham, who is 
also the Director of the Institute; cancer research led by Rick Kefford; the Storr Liver group headed 
by Geoffrey Farrell (who leaves us for Canberra in 2006); and the Institute for Immunology and 
Allergy Research directed by Graham Stewart have since been joined by the Centre for Vision 
Research, the Centre for Transplantation and Renal Research, the Institute for Dental Research 
and the Centre for Infectious Diseases and Microbiology. The Millennium Institute is a key 
component of the Westmead research hub and offers administrative support to other researchers in 
the clinical school. 
Currently the Institute’s research continues the themes of the individual groups and many are 
involved in large multicentre studies in Australia and internationally.
The Westmead Millenium Institute building
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National Centre for Immunisation Research and Surveillance of  
Vaccine-preventable Diseases
The rapidly expanding range of new vaccines for use in persons of all ages, as well as resurgence 
of traditional diseases such as pertussis, stimulated the establishment of the Centre in 1997, with 
funding mainly from NSW Health, the Children’s Hospital and contract research. The award 
of a Commonwealth tender in 1999 gave the Centre the security to embark on capacity building 
for surveillance and mathematical modelling with other units Australia-wide. The first director 
was Margaret Burgess who was succeeded by Peter McIntyre and his Co-Director Robert Booy 
in 2005. The Centre is housed in the RAHC research building at Westmead. The 20 research 
staff work almost entirely on epidemiologic projects but have strong relationships to laboratory 
research through the national sero-surveillance program and vaccine trials. Research achievements 
include pioneering adult pertussis vaccine trials, development of the justification for innovations in 
vaccine schedules, development of new nationally representative reports on the status of vaccine-
preventable diseases and evaluation of initiatives in immunisation for Indigenous people.
The George Institute (Formerly the Institute for International Health)
The George Institute for International Health (formerly known as the Institute for International 
Health) began operating in 1999 with the support of the University of Sydney Faculty of Medicine. 
The George Institute was established in response to the growing worldwide burden of non-
communicable disease and injury, particularly in the Asia-Pacific region. It owed its origins to the 
vision of its two principal directors and the guidance of John Chalmers. It was established on an 
independent charitable basis in 1999.
In December 2000 the Institute moved offices from the Royal North Shore Hospital campus to 
the Camperdown campus at the University of Sydney and established affiliations with Central 
Sydney Area Health Service (now Sydney South West Area Health Service) and Royal Prince 
Alfred Hospital. The Institute was renamed The George Institute for International Health in 
early 2004 to coincide with its move to larger premises in the refurbished King George V building 
within the Royal Prince Alfred Hospital campus. The Institute has since expanded into a second 
Sydney office, located in Kent Street and has established an office in Beijing (The China-Australia 
Partnership for Health and Centre for Evidence-based Medicine). Under the leadership of 
Principal Directors Robyn Norton and Stephen MacMahon of the Faculty of Medicine, the 
Institute and its research partners conduct:
• large-scale clinical, epidemiological and health services research studies
• evidence-based health policy development, implementation and evaluation 
• capacity building in epidemiology, clinical research, biostatistics and policy development.
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The Institute uses an 
Internet-based application 
as its principal data 
acquisition tool in its large-
scale research activities. 
Developed in-house, this 
application provides the full 
spectrum of data management 
functions, including data 
acquisition, validation, 
registration, randomisation, 
query resolution and 
reporting. All data acquisition 
transactions are encrypted 
and application systems 
are protected by firewalls and secured to industry standards. The application complies with the 
FDA 21 CFR Part 11 regulatory guidelines and the ICH Guidelines for Good Clinical Practice. 
All application systems are located in a custom-built data centre and are designed to operate 24 
hours, seven days a week. The George Institute collaborates with over 300 hospitals or research 
groups in 30 countries. These projects simultaneously involve dozens of investigators and as many 
as half a million participants.
The Institute’s activities are organised under Divisions and Programs including: Cardiac and 
Renal, Injury Prevention and Trauma Care Epidemiology and Biostatistics, Neurological Diseases 
and Ageing, Mental Health, and Policy and Practice. The China Program supports The George 
Institute Divisions to conduct their China-based research, policy or capacity building activities 
in cooperation with Chinese researchers and policy makers. The Operations team provides 
support to the Institute in the areas of information technology, finance and administration and 
human resources.
Institute for Bone and Joint Disease 
The Institute of Bone and Joint Research (IBJR) was established in 1999 under the leadership 
of Peter Ghosh to advance knowledge and understanding of the musculoskeletal system and 
diseases of bone, cartilage and joints, by bringing together the expertise of the Departments of 
Orthopaedics and Rheumatology. It is located at Royal North Shore Hospital and supported by 
the Bone and Joint Research Foundation of the University and also more recently the Lincoln 
Centre. Individual projects are currently funded from industry as well as peer-reviewed granting 
bodies including NHMRC, Arthritis Australia and the Northern Sydney and Central Coast 
Health Service.
George Institute Workshop in China
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The IBJR has particular research interests in the areas of osteoporosis, osteoarthritis, rheumatoid 
arthritis, spinal diseases (disc degeneration) and a focus on the epidemiology, diagnosis, 
pathogenesis and methods of treating these conditions. Basic and clinical research are presently 
undertaken in the Departments of Orthopaedics and Rheumatology and their associated 
laboratories, which include the Raymond Purves Bone and Joint Research Laboratories, Murray 
Maxwell Biomechanics Laboratory, and Sutton Arthritis Research Laboratories. IBJR also 
collaborates with the Institute of Magnetic Resonance Research and the ANZAC Institute.
The Institute is entering a new phase of development with the recent appointments of Philip 
Sambrook to succeed Peter Ghosh as Director, Chris Little to head the Raymond Purves 
Laboratories and Richard Appleyard to direct the Murray Maxwell Laboratory. Sambrook holds 
the Florance Cope Chair of Rheumatology, the first chair of rheumatology in Australia.
Australian Health Policy Institute 
The Australian Health Policy Institute (AHPI) was established by the College of Health Sciences 
in 1999 under the leadership of Stephen Leeder (the 16th Dean of the Faculty (1997–2002). Its 
purpose is to provide a high-level capability for authoritative, independent, non-partisan analysis 
of major health policy questions which confront Australian and international health systems. The 
Institute has four themes: futures, equity, serious and continuing illness, and governance. Institute 
staff collaborate extensively with government and non-government organisations, locally and 
internationally, on a range of research projects. Health policy colloquium and seminar programs 
are also conducted by the Institute to promote academic, professional and public debate on policy 
issues. The Institute provides an educational capacity in health policy, policy analysis and policy 
research in the College’s teaching programs.
 
The Australian Health Policy Institute has established a Diabetes Unit to complement existing 
AHPI programs. The Unit will have an explicit focus on policy, planning and health system reform 
activities across the continuum of primary, secondary and tertiary prevention in relation to diabetes 
and associated chronic diseases. In 2006 the Australian Health Policy Institute and the School of 
Public Health will launch a new postgraduate program in health policy, filling a large gap in current 
professional training. 
Australian Centre for Agricultural Health and Safety
The Centre, which opened in 2001, evolved from initiatives within the Moree Area Health Service 
to improve the health of people living and working on Australian farms. The founder director is 
Lyn Fragar. Its core activity is the maintenance of the National Farm Injury Database and the 
Centre is involved in many specific projects to monitor and prevent accidents and illness related 
to use of farm machinery, agricultural chemicals and pesticides. Based in Moree, the Centre is 
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closely linked to the University School of Public Health and also has affiliations with the University 
Faculty of Agriculture. The Centre’s infrastructure is supported by the NSW Department of 
Health and a partnership with Australian Rural Health Research Collaboration, but most research 
is supported by specific project grants. The Centre produces many reports and educational 
publications about health and safety issues for farmers and their families.
Australian Red Cross blood service research Unit of Transfusion Medicine and 
Immunogenetics
In 2002 the Unit was established under the leadership of Andrew Geczy to formalise a research 
partnership between the Red Cross and the Faculty’s Central Clinical School. The Research 
Unit, equipped with state-of-the-art facilities, staffed by scientists with diverse skills and with 
collaborative links with scientists from many institutions, is well placed to tackle fundamental 
problems in laboratory and clinical medicine.
The Molecular Genetics section is using new technologies to focus on immunogenetics, population 
genetics and anthropology, allowing for the identification and characterisation of many novel gene 
variants. The Proteomics group has been studying the composition and mechanism of action of 
blood products to understand mechanisms that underlie adverse reactions to blood transfusions. 
The Cell and Tissue group studies the functional aspects of transplantation through analysis of 
cellular cytokine production to understand and predict transplant outcome while the Cell Biology 
group has produced a range of murine and human monoclonal antibodies for use as diagnostic as 
well as potential therapeutic agents.
The Viral Immunology group has been investigating immunological responses to viral diseases 
such as HIV-1, Hepatitis C, and Smallpox, using a novel antibody array technology. The unit 
offers specialist training for registrars and medical technologists from Australasia as well as from 
South East Asia.
The Brain and Mind Institute Research Foundation 
Neurosciences has been a major strand of research in the Faculty since its inception (see Chapter 3) 
and over recent years a virtual institute has emerged in Faculty linking the basic sciences with 
clinical neurology and psychological medicine. 
The Brain and Mind Research Institute (BMRI) officially opened in 2004 in its new buildings 
in Mallet Street, was established to integrate clinical and basic neurosciences research. Through 
discovery, innovative and integrative research strategies, clinical product development and the 
application of research initiatives, the BMRI directly benefits people whose lives have been affected 
by the common and debilitating forms of psychiatric and neurological illness. 
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BMRI is a multidisciplinary research group located under one roof in a converted factory building 
in Mallet Street close to the Prince Alfred and University campuses. This initiative stems from 
the vision of Max Bennett whose own research concerns the mechanisms of nerve transmission 
and has been brought to fulfilment with the support of John Pollard, a clinical neurologist, and 
Ian Hickie, a psychiatrist. With Hickie as Director and substantial Commonwealth funding, the 
first research groups are now moving into the building which is equipped for advanced functional 
neuro-imaging (under the leadership of Richard Banati of the Faculty of Health Sciences) as well as 
housing a clinical trials centre. The development of this institute helped faculty recruit a dynamic 
Alzheimer’s researcher, Jürgen Götz from Switzerland. The study of depression will be one of the 
major themes of the institute in the coming years. 
South-West Area Health Service Drug and Alcohol Unit
The Drug and Alcohol Unit commenced with a consultation service for inpatients of Royal Prince 
Alfred Hospital led by Frank Harding Burns in the 1970s. A detoxification centre (Basement 82) 
was opened in 1982 and other clinical services followed. An important early study from the unit 
identified the very high prevalence of alcohol use disorders amongst hospital inpatients. Clinical 
Psychologist T Sitharthan ran controlled drinking groups and was successful in establishing a 
Controlled Drinking by Correspondence program for people in rural and isolated areas. Another 
milestone was the establishment of the pioneering Drugs in Pregnancy Service by Edith Collins. 
Under the direction of John Saunders the unit was then formally constituted as a research unit 
with a focus on early intervention led by Kate Conigrave. Paul Haber has been academic head 
of the unit since 1998 and the unit is actively developing treatment related (pharmacotherapy) 
research projects.
The changed administrative environment of the University has created a need for grouping of 
campus based research interests into the Institute model. The Institute for Biomedical Research 
and the Sydney University Biological Informatics and Technology Centre and the Centre for 
Values Ethics and the Law in Medicine (below) are all manifestations of this process.
Imaging of the brain
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Sydney University Biological Informatics and Technology Centre (Sydney University 
Prince Alfred Macromolecular Analysis Centre – SUPAMAC
SUPAMAC was formed 10 years ago when researchers at the University and the Royal Prince 
Alfred Hospital agreed to co-locate expensive high technology DNA analytic platforms to the one 
location. These cover DNA sequencing, microsatellite analysis, single nucleotide polymorphism 
testing and denaturing high-performance liquid chromatography. Highly experienced staff 
operate this equipment and are available to help researchers with their experimental problems, and 
workshops are held at the beginning of the academic year for new researchers. 
SUPAMAC has come a long way since the first few years when the Pro-Vice-Chancellor 
(Research) needed to subsidise the operation. Today, SUPAMAC makes a small annual profit 
on its work which is returned to upgrade or purchase new equipment. Over 33,000 specimens 
were referred to SUPAMAC in 2005 from customers who come from within and external to the 
University. Royal Prince Alfred Hospital has been a vital supporter of SUPAMAC, coming to its 
rescue on many occasions. Key players contributing 
to the development of SUPAMAC over its decade of 
service include Ron Trent (Executive Director), Bing 
Yu and Lee Huong (Honorary Consultants), Craig 
Williams and Evan Dodds (Research Assistants), 
and Loletta Yuen (Administrative Officer). Nicole 
Sawyer, the recently appointed Research and 
Development Director, provides SUPAMAC with a 
promising long-term future. 
Institute for Biomedical Research 
The Institute was founded in 1995 as a way of coordinating the ongoing research in the Faculty’s 
founding disciplines of Anatomy/Histology and Physiology. It is governed by a Board of Directors 
drawn from science and the community and is guided by an international scientific advisory 
committee. In 2002 the Institute expanded to incorporate the academic staff of the disciplines of 
Pathology and Pharmacology. There are also a number of other members, in particular researchers 
associated with the Central Clinical School.
The current aims and goals of the Institute are encompassed in its Vision Statement (2004): 
To perform high quality research into the normal functioning of the human body
To perform high quality research into the causes, prevention, detection and treatment of 
human diseases
To provide outstanding training for junior scientists in the intellectual, practical and 
ethical aspects of biomedical research
SUPAMAC
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The central staff of the Institute consists of the Director, Assistant to the Director, Molecular 
Biology Officer and Microscopy Officer. The research work within the Institute for Biomedical 
Research is carried out by its members (academic staff associated with the School of Medical 
Sciences) and others invited to join. There has been a strong growth in the numbers of clinically 
active researchers from 2003 onwards.
Members of the Institute produce 
major contributions to basic 
medical research across most of the 
body systems using a wide variety 
of technologies. 
There is no central Institute building 
and most of the researchers are 
located in the Anderson Stuart 
and Blackburn Buildings although 
some have recently occupied 
modern laboratories in the Medical 
Foundation Building. There are 
two major multi-user facilities: the Advanced Imaging Facility and Molecular Biology Facility, 
which contain major items of equipment and are used by over 20 groups throughout the Institute. 
They are managed by PhD-qualified officers who also perform an important training function. 
The Institute currently is developing a PC2 facility in the Anderson Stuart Building and a second 
Molecular Biology facility in the Blackburn Building. 
Scientific meetings, which have been held approximately annually since the Institute was founded 
in 1995, have showcased the work of the Institute’s postgraduate students and postdoctoral fellows. 
The annual scientific meeting has 
been a major intellectual component 
of the Institute’s work. Research 
students and postdoctoral researchers 
also organise their own regular 
seminars and an annual Young 
Investigator Symposium.
Despite their teaching commitments, 
the members of the Institute attracted 
approximately $18 million in peer-
reviewed research funding in 2001–03 
and $4 million from industry. Around 
Acoustic chamber for directional hearing, 
Institute for Biomedical Research
Research in developmental biology, 
Institute for Biomedical Research
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400 scientific articles were published in 2002–2003. Individual members have won many national 
and international awards for their research achievements.
The Instiute for Biomedical Research will soon be known as the Bosch Institute.
Centre for Values, Ethics and the Law in Medicine
The Centre for Values, Ethics and the Law in Medicine, Faculty of Medicine, University of 
Sydney, was established in 1995 (and recognised as an official University Centre in 1996) because 
a number of doctors were concerned that health services were failing to deliver what ill people were 
looking for. It seemed to them that medical science and technology were advancing faster than 
bioethics and the law, and that rationalist economics and management principles were failing to 
control the costs of health.
Miles Little was the driving force in its creation and became the first Director. The Centre 
proposed to fill five major functions: research (predominantly qualitative) and research supervision, 
advanced education for graduates, consultation on issues beyond those normally tackled by 
research ethics committees, an intellectual forum for researchers working in areas of wide social 
interest, and a source of community education. Little raised money from a variety of sources to 
pay three research salaries, and recruited a voluntary ‘Core Group’ from interested people of many 
disciplines, including Medicine, Philosophy, Ethics, Law, Theology, Sociology and Anthropology. 
The Centre has hosted several visiting scholars from abroad, supervised research students and 
maintained a stream of scholarly publications in the medical and philosophical literature. Its 
present director is Ian Kerridge who joined Faculty in 2003. (See Chapter 3).
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The role of the institutes
Whilst no one would gainsay the success of some of NSW’s medical research institutes, there is 
considerable debate about how truly independent they are (or should be) from the state’s major 
research intensive universities. From this account it is evident that there are many different models 
of research centres affiliated with Faculty. Some are relatively independent, although some staff 
may hold University titles and supervise research students. Others are fully controlled entities of 
the University, while some are hospital-owned research centres with research affiliations with the 
Faculty and some are in effect joint hospital-University ventures. 
Recent events suggest that the need to stress independence has been removed and in future the 
institutes will once again be encouraged to develop their strong University affiliations. There is no 
doubt, however, that the dramatic growth of medical research in the state has come about through 
the strong growth of the institutes, and they form an essential part of the history of the Faculty of 
Medicine at the University of Sydney. 
